Chemical industry – Page 106
-
-
CareersTaking a Dip in cosmetics
Yfke Hager takes a look at a distance learning course that gets under the skin of the cosmetics industry
-
Business
Dow tax case raises R&D questions
US court blocks Dow attempt to recoup costs under the R&D tax credit scheme
-
Business
Solvay adds fluorinated capacity
Company will double capacity at plant in Salindres, France, which makes triflic acid
-
BusinessBASF backs automotive growth
While other chemical companies are trying to reduce their exposure to the automotive industry, BASF is heading in the other direction
-
BusinessLow salt diet to flush out oil
Better understanding of oil–clay chemistry could increase the world’s recoverable oil by billions of barrels
-
Business
Merck KGaA to cut 1100 German jobs
Company provides detail of restructuring programme announced in February
-
Business
Kevlar equivalent banned for 20 years
US rules in favour of DuPont in Kevlar trade secrets case
-
Business
DuPont sells car paints for $5bn
US investment group picks up 11,000 employees and $4 billion in annual sales
-
NewsDrug maker apologises for thalidomide tragedy
Fifty years after the event Grünenthal issues an apology as victims of the drug continue to press for compensation
-
Business
Rockwood to pay C$720m for lithium firm
The chemical group has struck a deal to buy Talison, an Australian lithium producer with headquarters in Perth.
-
Business
Myelofibrosis drug approved in EU
Jakavi (ruxolitinib) tablets are for the treatment of myelofibrosis, a rare disease affecting the bone marrow
-
BusinessCrowdsourcing science site to launch
Marblar aims to find uses for neglected patents by ‘gamifying’ the technology transfer process
-
Business
Alzheimer's drug flops in Phase III
Solanezumab from Eli Lilly missed the cognitive and functional primary endpoints of the trials
-
Business
Merck KGaA buys cell culture company
Biochrom makes cell culture media and buffer solutions
-
Business
Flight fuelled by plastic waste
Liquid fuel made entirely from plastic waste will power a single engine plane from from London to Sydney
-
Business
Generic Actos approved
Mylan, Ranbaxy and Teva have won US marketing approval for their generic versions of Actos diabetes tablets
-
Business
Pfizer to pay $250m for Nexium
AstraZeneca has sold rights to an over the counter version of its heartburn tablets